[go: up one dir, main page]

ATE398174T1 - Methode zur herstellung funktioneller proteindomänen - Google Patents

Methode zur herstellung funktioneller proteindomänen

Info

Publication number
ATE398174T1
ATE398174T1 AT01953251T AT01953251T ATE398174T1 AT E398174 T1 ATE398174 T1 AT E398174T1 AT 01953251 T AT01953251 T AT 01953251T AT 01953251 T AT01953251 T AT 01953251T AT E398174 T1 ATE398174 T1 AT E398174T1
Authority
AT
Austria
Prior art keywords
functional protein
protein domain
producing functional
producing
domain
Prior art date
Application number
AT01953251T
Other languages
English (en)
Inventor
Luca Giampiero De
Luca Falciola
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE398174T1 publication Critical patent/ATE398174T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/42Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT01953251T 2000-08-01 2001-08-01 Methode zur herstellung funktioneller proteindomänen ATE398174T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018876.3A GB0018876D0 (en) 2000-08-01 2000-08-01 Method of producing polypeptides

Publications (1)

Publication Number Publication Date
ATE398174T1 true ATE398174T1 (de) 2008-07-15

Family

ID=9896767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01953251T ATE398174T1 (de) 2000-08-01 2001-08-01 Methode zur herstellung funktioneller proteindomänen

Country Status (20)

Country Link
US (1) US8048645B2 (de)
EP (1) EP1305411B1 (de)
JP (1) JP5068916B2 (de)
CN (1) CN1468304B (de)
AR (1) AR031717A1 (de)
AT (1) ATE398174T1 (de)
AU (1) AU7573901A (de)
BR (1) BR0112979A (de)
CA (1) CA2415768C (de)
CY (1) CY1110431T1 (de)
DE (1) DE60134410D1 (de)
DK (1) DK1305411T3 (de)
ES (1) ES2305091T3 (de)
GB (1) GB0018876D0 (de)
IL (1) IL154212A0 (de)
NO (1) NO330897B1 (de)
PT (1) PT1305411E (de)
SI (1) SI1305411T1 (de)
WO (1) WO2002010372A1 (de)
ZA (1) ZA200300827B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
EP2058329B1 (de) * 2003-06-10 2010-08-18 NsGene A/S Verbesserte Sekretion von Neublastin
WO2008027558A2 (en) 2006-08-31 2008-03-06 Codon Devices, Inc. Iterative nucleic acid assembly using activation of vector-encoded traits
US20120315670A1 (en) * 2009-11-02 2012-12-13 Gen9, Inc. Compositions and Methods for the Regulation of Multiple Genes of Interest in a Cell
EP2637780B1 (de) 2010-11-12 2022-02-09 Gen9, Inc. Proteinanordnungen und verfahren zu ihrer herstellung und verwendung
EP3360963B1 (de) 2010-11-12 2019-11-06 Gen9, Inc. Verfahren und vorrichtungen für nukleinsäuresynthese
LT3594340T (lt) 2011-08-26 2021-10-25 Gen9, Inc. Kompozicijos ir būdai, skirti nukleorūgščių didelio tikslumo sąrankai
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
EP2841601B1 (de) 2012-04-24 2019-03-06 Gen9, Inc. Verfahren zum sortieren von nukleinsäuren und zur multiplexierten, vorbereitenden in-vitro-klonung
EP3483311B8 (de) 2012-06-25 2025-10-29 Ginkgo Bioworks, Inc. Verfahren zur nukleinsäurezusammenfügung und -sequenzierung mit hohem durchsatz
GB2533173A (en) 2013-08-05 2016-06-15 Twist Bioscience Corp De Novo synthesized gene libraries
CA2975855C (en) 2015-02-04 2025-09-23 Twist Bioscience Corporation SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS
WO2016126882A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
AU2016324296A1 (en) 2015-09-18 2018-04-12 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
WO2017095958A1 (en) 2015-12-01 2017-06-08 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
CA3034769A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
JP6871364B2 (ja) 2016-09-21 2021-05-12 ツイスト バイオサイエンス コーポレーション 核酸に基づくデータ保存
AU2017378492B2 (en) 2016-12-16 2022-06-16 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
EP4556433A3 (de) 2017-02-22 2025-08-06 Twist Bioscience Corporation Nukleinsäurebasierte datenspeicherung
AU2018234629A1 (en) 2017-03-15 2019-10-17 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
KR102784398B1 (ko) 2017-06-12 2025-03-19 트위스트 바이오사이언스 코포레이션 심리스 핵산 어셈블리를 위한 방법
GB2581620A (en) 2017-09-11 2020-08-26 Twist Bioscience Corp GPCR binding proteins and synthesis thereof
GB2583590A (en) 2017-10-20 2020-11-04 Twist Bioscience Corp Heated nanowells for polynucleotide synthesis
KR102804057B1 (ko) 2018-01-04 2025-05-07 트위스트 바이오사이언스 코포레이션 Dna 기반 디지털 정보 저장
EP3814497A4 (de) 2018-05-18 2022-03-02 Twist Bioscience Corporation Polynukleotide, reagenzien und verfahren zur nukleinsäurehybridisierung
CA3124980A1 (en) 2018-12-26 2020-07-02 Twist Bioscience Corporation Highly accurate de novo polynucleotide synthesis
WO2020176678A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
SG11202109283UA (en) 2019-02-26 2021-09-29 Twist Bioscience Corp Variant nucleic acid libraries for antibody optimization
EP3987019A4 (de) 2019-06-21 2023-04-19 Twist Bioscience Corporation Barcode-basierte nukleinsäuresequenzanordnung
EP4464827A3 (de) 2019-09-23 2025-02-26 Twist Bioscience Corporation Varianten von nukleinsäurebibliotheken für crth2
CA3155630A1 (en) 2019-09-23 2021-04-01 Twist Bioscience Corporation Variant nucleic acid libraries for single domain antibodies
MX2023003481A (es) 2020-09-28 2023-06-02 Vestaron Corp Polipéptidos variantes de mu-diguetoxina-dc1a para el control de plagas.
CA3217862A1 (en) 2021-05-05 2022-11-10 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
DE69027526T3 (de) 1989-11-06 2005-03-24 Cell Genesys, Inc., Foster City Herstellung von proteinen mittels homologer rekombination
EP0779362B2 (de) 1989-12-22 2012-06-13 Laboratoires Serono SA DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
WO1993004169A1 (en) * 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
US5545817A (en) * 1994-03-11 1996-08-13 Calgene, Inc. Enhanced expression in a plant plastid
WO1997023244A1 (en) 1995-12-22 1997-07-03 Smithkline Beecham Corporation Use of antisene oligodeoxynucleotides to produce truncated proteins
CA2304642C (en) * 1997-09-26 2014-11-18 Athersys, Inc. Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
US7063960B2 (en) * 1997-12-12 2006-06-20 The Rockefeller University Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
DE69939056D1 (de) * 1998-03-27 2008-08-21 Lexicon Pharmaceuticals Inc Vektoren für genmutagenese und genentdeckung
JP3688118B2 (ja) * 1998-05-22 2005-08-24 独立行政法人科学技術振興機構 遺伝子トラップ用ベクターと、このベクターを用いた遺伝子トラップ方法

Also Published As

Publication number Publication date
AU7573901A (en) 2002-02-13
JP2004504840A (ja) 2004-02-19
IL154212A0 (en) 2003-07-31
CA2415768C (en) 2011-05-17
NO330897B1 (no) 2011-08-08
ZA200300827B (en) 2004-02-25
SI1305411T1 (sl) 2008-10-31
ES2305091T3 (es) 2008-11-01
CA2415768A1 (en) 2002-02-07
US20040053362A1 (en) 2004-03-18
HK1059281A1 (en) 2004-06-25
NO20030443D0 (no) 2003-01-28
DK1305411T3 (da) 2008-09-01
WO2002010372A1 (en) 2002-02-07
JP5068916B2 (ja) 2012-11-07
AR031717A1 (es) 2003-10-01
CN1468304A (zh) 2004-01-14
CY1110431T1 (el) 2015-04-29
EP1305411B1 (de) 2008-06-11
GB0018876D0 (en) 2000-09-20
NO20030443L (no) 2003-03-25
CN1468304B (zh) 2011-01-19
PT1305411E (pt) 2008-07-03
EP1305411A1 (de) 2003-05-02
US8048645B2 (en) 2011-11-01
WO2002010372A8 (en) 2002-02-28
DE60134410D1 (de) 2008-07-24
BR0112979A (pt) 2003-07-08

Similar Documents

Publication Publication Date Title
ATE398174T1 (de) Methode zur herstellung funktioneller proteindomänen
DE60144508D1 (de) Verfahren zur Herstellung von Proben
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
ATE300520T1 (de) Verfahren zur herstellung amlodipinmaleat
ATE394475T1 (de) Methode zur herstellung von infektiösem reovirus
ATE324794T1 (de) Haustierfutter und verfahren zur herstellung
ATE281448T1 (de) Verfahren zur herstellung von citalopram
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE50101607D1 (de) Verfahren zur herstellung von bisphenolen
ATE328885T1 (de) Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen
DE60027932D1 (de) Verfahren zur herstellung von proteinhydrolysaten
DE60222046D1 (de) Verfahren zur Herstellung HBT-Anordnungen
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60123824D1 (de) Verfahren zur herstellung veresterter kondensate
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE266004T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- methylpyridin
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE516267T1 (de) Vefahren zur herstellung von lactamen
ATE389645T1 (de) Verfahren zur herstellung von citalopram
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305411

Country of ref document: EP

EEFA Change of the company name